Brenda Motheral

Pharmacoeconomist, Pharmaceutical Policy Expert, Healthcare Executive, Published Author, Disease Management Expert, Academician

[Brenda Motheral @RxOutcomePhD]

PRESS RELEASE:: Artemetrx Releases a Specialty Drug Trend Study -
Specialty Drug Costs Are Spiraling http://t.co/ItGWBObj

[Brenda Motheral @RxOutcomePhD]

PBMI announces Dr. Gilbert Welch, author of OverDiagnosed, and Barrett Toan, former ESI CEO, as speakers for their 2012 annual conference

[Brenda Motheral @RxOutcomePhD]

#PBMI announces Dr. Gilbert Welch, author of OverDiagnosed, and Barrett Toan, former ESI CEO, as speakers for their 2012 annual conference

[Brenda Motheral @RxOutcomePhD]

PBMI Releases the 2011-2012 Prescription Drug Benefit Cost and Plan Design Report http://t.co/yEB94mQa

[Brenda Motheral @RxOutcomePhD]

Where Should Copays be Set for Specialty Drugs? http://wp.me/p1dZrC-46

[Brenda Motheral @RxOutcomePhD]

Do Cost-Effectiveness Models Need a Reality Check? http://wp.me/p1dZrC-3Z

[Brenda Motheral @RxOutcomePhD]

New Study Finds Reference Pricing Saves Big Money http://wp.me/p1dZrC-3P

[Brenda Motheral @RxOutcomePhD]

When Are Prescription Copay Waivers a Good Idea? http://wp.me/p1dZrC-3A

[Brenda Motheral @RxOutcomePhD]

Does Makena Actually Have a Favorable Pharmacoeconomic Profile? http://wp.me/p1dZrC-3s

[Brenda Motheral @RxOutcomePhD]

Persistency Is The Best Measure of Medication Adherence http://wp.me/p1dZrC-3h

[Brenda Motheral @RxOutcomePhD]

What is the best measure of medication adherence? http://wp.me/p1dZrC-3c

[Brenda Motheral @RxOutcomePhD]

Tis The Season for Drug Trend Reports http://wp.me/p1dZrC-2W

[Brenda Motheral @RxOutcomePhD]

Study Shows Slight Preference Advantage for Community Pharmacy Over Mail Pharmacy http://wp.me/p1dZrC-2J

[Brenda Motheral @RxOutcomePhD]

JMCP Publishes Editorial on VBID: What Do We Really Know? http://wp.me/p1dZrC-2z

[Brenda Motheral @RxOutcomePhD]

What Do We Really Know About Step Therapy for Pharmaceuticals? http://wp.me/p1dZrC-2s

[Brenda Motheral @RxOutcomePhD]

Can You Reduce Risk Through Outcomes-Based Contracting for Pharmaceuticals? http://wp.me/p1dZrC-2i

[Brenda Motheral @RxOutcomePhD]

Two Things You Must Know About Employee Wellness Incentive Programs http://wp.me/p1dZrC-20

[Brenda Motheral @RxOutcomePhD]

Are Statins Cost-Effective for Primary Prevention? http://wp.me/p1dZrC-1R

[Brenda Motheral @RxOutcomePhD]

U.S. Drug Prices 3- to 6-Fold Greater Than Other Countries http://wp.me/p1dZrC-1K

[Brenda Motheral @RxOutcomePhD]

ACOs, Pharmacists, and Transitional Care: A Winning Strategy: http://wp.me/p1dZrC-1E